[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Multiple Sclerosis Drugs Market Report 2016

November 2016 | 104 pages | ID: E4B01834E0AEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Multiple Sclerosis Drugs

Revenue, means the sales value of Multiple Sclerosis Drugs

This report studies sales (consumption) of Multiple Sclerosis Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Biogen
  • Teva Pharmaceutical
  • Merck KGaA
  • Novartis
  • Bayer
  • Sanofi
  • Acorda Therapeutics
  • Questcor Pharmaceuticals
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Multiple Sclerosis Drugs in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Multiple Sclerosis Drugs in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Multiple Sclerosis Drugs Market Report 2016

1 MULTIPLE SCLEROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis Drugs
1.2 Classification of Multiple Sclerosis Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Multiple Sclerosis Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Multiple Sclerosis Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Multiple Sclerosis Drugs (2011-2021)
  1.5.1 Europe Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE MULTIPLE SCLEROSIS DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Multiple Sclerosis Drugs Market Competition by Manufacturers
  2.1.1 Europe Multiple Sclerosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Multiple Sclerosis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Multiple Sclerosis Drugs (Volume and Value) by Type
  2.2.1 Europe Multiple Sclerosis Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Multiple Sclerosis Drugs (Volume and Value) by Countries
  2.3.1 Europe Multiple Sclerosis Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Multiple Sclerosis Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Multiple Sclerosis Drugs (Volume) by Application

3 GERMANY MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Multiple Sclerosis Drugs Sales and Value (2011-2016)
  3.1.1 Germany Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
3.2 Germany Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
3.3 Germany Multiple Sclerosis Drugs Sales and Market Share by Type
3.4 Germany Multiple Sclerosis Drugs Sales and Market Share by Application

4 FRANCE MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Multiple Sclerosis Drugs Sales and Value (2011-2016)
  4.1.1 France Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
4.2 France Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
4.3 France Multiple Sclerosis Drugs Sales and Market Share by Type
4.4 France Multiple Sclerosis Drugs Sales and Market Share by Application

5 UK MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Multiple Sclerosis Drugs Sales and Value (2011-2016)
  5.1.1 UK Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
5.2 UK Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
5.3 UK Multiple Sclerosis Drugs Sales and Market Share by Type
5.4 UK Multiple Sclerosis Drugs Sales and Market Share by Application

6 RUSSIA MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Multiple Sclerosis Drugs Sales and Value (2011-2016)
  6.1.1 Russia Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
6.2 Russia Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
6.3 Russia Multiple Sclerosis Drugs Sales and Market Share by Type
6.4 Russia Multiple Sclerosis Drugs Sales and Market Share by Application

7 ITALY MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Multiple Sclerosis Drugs Sales and Value (2011-2016)
  7.1.1 Italy Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
7.2 Italy Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
7.3 Italy Multiple Sclerosis Drugs Sales and Market Share by Type
7.4 Italy Multiple Sclerosis Drugs Sales and Market Share by Application

8 SPAIN MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Multiple Sclerosis Drugs Sales and Value (2011-2016)
  8.1.1 Spain Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
8.2 Spain Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
8.3 Spain Multiple Sclerosis Drugs Sales and Market Share by Type
8.4 Spain Multiple Sclerosis Drugs Sales and Market Share by Application

9 BENELUX MULTIPLE SCLEROSIS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Multiple Sclerosis Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
9.2 Benelux Multiple Sclerosis Drugs Sales and Market Share by Manufacturers
9.3 Benelux Multiple Sclerosis Drugs Sales and Market Share by Type
9.4 Benelux Multiple Sclerosis Drugs Sales and Market Share by Application

10 EUROPE MULTIPLE SCLEROSIS DRUGS MANUFACTURERS ANALYSIS

10.1 Biogen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Teva Pharmaceutical
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck KGaA
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Bayer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Sanofi
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Acorda Therapeutics
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Questcor Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Multiple Sclerosis Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 MULTIPLE SCLEROSIS DRUGS MANUFACTURING COST ANALYSIS

11.1 Multiple Sclerosis Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Multiple Sclerosis Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE MULTIPLE SCLEROSIS DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.2 France Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.3 UK Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.4 Russia Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.5 Italy Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.6 Spain Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.7 Benelux Multiple Sclerosis Drugs Sales Forecast (2016-2021)
14.8 Europe Multiple Sclerosis Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Multiple Sclerosis Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Sclerosis Drugs
Table Classification of Multiple Sclerosis Drugs
Figure Europe Sales Market Share of Multiple Sclerosis Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Multiple Sclerosis Drugs
Figure Europe Sales Market Share of Multiple Sclerosis Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure France Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure UK Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Multiple Sclerosis Drugs Sales and Growth Rate (2011-2021)
Figure Europe Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2021)
Table Europe Multiple Sclerosis Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Multiple Sclerosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Multiple Sclerosis Drugs Sales Share by Manufacturers
Figure 2016 Multiple Sclerosis Drugs Sales Share by Manufacturers
Table Europe Multiple Sclerosis Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Multiple Sclerosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table 2016 Europe Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table Europe Multiple Sclerosis Drugs Sales and Market Share by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure Europe Multiple Sclerosis Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Multiple Sclerosis Drugs by Type (2011-2016)
Figure Europe Multiple Sclerosis Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Countries (2011-2016)
Table Europe Multiple Sclerosis Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Multiple Sclerosis Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Multiple Sclerosis Drugs by Countries (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales and Market Share by Application (2011-2016)
Table Europe Multiple Sclerosis Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Multiple Sclerosis Drugs by Application (2011-2016)
Figure Germany Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Germany Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Germany Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table Germany Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table Germany Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table Germany Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure France Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure France Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure France Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table France Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table France Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table France Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table France Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table France Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table France Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure UK Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure UK Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure UK Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table UK Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table UK Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table UK Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table UK Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table UK Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure Russia Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Russia Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Russia Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table Russia Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table Russia Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table Russia Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure Italy Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Italy Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Italy Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table Italy Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table Italy Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table Italy Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure Spain Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Spain Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Spain Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table Spain Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table Spain Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table Spain Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Figure Benelux Multiple Sclerosis Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Multiple Sclerosis Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Multiple Sclerosis Drugs Sales Price Trend (2011-2016)
Table Benelux Multiple Sclerosis Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Multiple Sclerosis Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Multiple Sclerosis Drugs Sales by Type (2015 and 2016)
Table Benelux Multiple Sclerosis Drugs Market Share by Type (2015 and 2016)
Table Benelux Multiple Sclerosis Drugs Sales by Application (2015 and 2016)
Table Benelux Multiple Sclerosis Drugs Market Share by Application (2015 and 2016)
Table Multiple Sclerosis Drugs Basic Information List
Table Biogen Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Merck KGaA Basic Information List
Table Merck KGaA Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Acorda Therapeutics Basic Information List
Table Acorda Therapeutics Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acorda Therapeutics Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Questcor Pharmaceuticals Basic Information List
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Multiple Sclerosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
Table Major Buyers of Multiple Sclerosis Drugs
Table Distributors/Traders List
Figure Germany Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Multiple Sclerosis Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Multiple Sclerosis Drugs Sales Forecast by Type (2016-2021)
Table Europe Multiple Sclerosis Drugs Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories